These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29111316)

  • 1. Concentrations of SP-A and HSP70 are associated with polarization of macrophages in pleural effusions of non-small cell lung cancer.
    Kaczmarek M; Lagiedo M; Masztalerz A; Kozlowska M; Nowicka A; Brajer B; Batura-Gabryel H; Sikora J
    Immunobiology; 2018 Feb; 223(2):200-209. PubMed ID: 29111316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer.
    Ho CC; Liao WY; Wang CY; Lu YH; Huang HY; Chen HY; Chan WK; Chen HW; Yang PC
    Am J Respir Crit Care Med; 2008 Apr; 177(7):763-70. PubMed ID: 18096709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation.
    Gu FF; Wu JJ; Liu YY; Hu Y; Liang JY; Zhang K; Li M; Wang Y; Zhang YA; Liu L
    Cancer Immunol Immunother; 2020 May; 69(5):779-788. PubMed ID: 32052078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW
    Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the phenotype pattern of macrophages isolated from malignant and non-malignant pleural effusions.
    Kaczmarek M; Nowicka A; Kozłowska M; Zurawski J; Batura-Gabryel H; Sikora J
    Tumour Biol; 2011 Dec; 32(6):1123-32. PubMed ID: 21809139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1 and Th2 cytokine profiles in malignant pleural effusion.
    Ghayumi MA; Mojtahedi Z; Fattahi MJ
    Iran J Immunol; 2011 Dec; 8(4):195-200. PubMed ID: 22201616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
    Tamiya M; Tamiya A; Yasue T; Nakao K; Omachi N; Shiroyama T; Tani E; Hamaguchi M; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Hirashima T
    Anticancer Res; 2016 Jun; 36(6):2939-44. PubMed ID: 27272808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Damage-Associated Molecular Patterns in the Course of Lung Cancer--A Review.
    Łagiedo M; Sikora J; Kaczmarek M
    Scand J Immunol; 2015 Aug; 82(2):95-101. PubMed ID: 25966741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the immunological microenvironment at the tumor site in patients with non-small cell lung cancer.
    Li R; Rüttinger D; Li R; Si LS; Wang YL
    Langenbecks Arch Surg; 2003 Dec; 388(6):406-12. PubMed ID: 14504933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
    Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and Tumor Th1 and Th2 Inflammatory Profile and Macrophages in Lung Cancer: Influence of Underlying Chronic Respiratory Disease.
    Mateu-Jimenez M; Curull V; Pijuan L; Sánchez-Font A; Rivera-Ramos H; Rodríguez-Fuster A; Aguiló R; Gea J; Barreiro E
    J Thorac Oncol; 2017 Feb; 12(2):235-248. PubMed ID: 27793775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
    Zhou WB; Bai M; Jin Y
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant mesothelioma: therapeutic implications.
    Donnenberg AD; Luketich JD; Donnenberg VS
    Oncotarget; 2019 Nov; 10(60):6456-6465. PubMed ID: 31741710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversing the polarization of tumor-associated macrophages inhibits tumor metastasis.
    Yuan R; Li S; Geng H; Wang X; Guan Q; Li X; Ren C; Yuan X
    Int Immunopharmacol; 2017 Aug; 49():30-37. PubMed ID: 28550732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteome screening of pleural effusions identifies IL1A as a diagnostic biomarker for non-small cell lung cancer.
    Li Y; Lian H; Jia Q; Wan Y
    Biochem Biophys Res Commun; 2015 Feb; 457(2):177-82. PubMed ID: 25554695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal-derived factor-1alpha/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space.
    Oonakahara K; Matsuyama W; Higashimoto I; Kawabata M; Arimura K; Osame M
    Am J Respir Cell Mol Biol; 2004 May; 30(5):671-7. PubMed ID: 14672915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.
    Zebrowski BK; Yano S; Liu W; Shaheen RM; Hicklin DJ; Putnam JB; Ellis LM
    Clin Cancer Res; 1999 Nov; 5(11):3364-8. PubMed ID: 10589746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer.
    Duan MC; Han W; Jin PW; Wei YP; Wei Q; Zhang LM; Li JC
    Inflammation; 2015 Dec; 38(6):2156-65. PubMed ID: 26077695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.